Primecap Management Co. CA Has $6.54 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Primecap Management Co. CA decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 88.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,920 shares of the healthcare conglomerate's stock after selling 103,544 shares during the period. Primecap Management Co. CA's holdings in UnitedHealth Group were worth $6,536,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $40,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UNH traded up $0.09 during midday trading on Monday, reaching $516.94. 3,840,856 shares of the company's stock were exchanged, compared to its average volume of 4,087,242. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $472.85 billion, a price-to-earnings ratio of 33.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The business has a 50-day simple moving average of $510.19 and a two-hundred day simple moving average of $546.71. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. The business's revenue was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. KeyCorp reissued an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Finally, Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.